NCT04520906

To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer

Prospective, Multicenter, Single-group Target Study to Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 61 (actual)
• Sponsor: Suzhou Hengruihongyuan Medical Technology Co. LTD · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Through the implementation of prospective, multi-center, single-group target value research to verify the safety and effectiveness of the microwave ablation treatment system for the ablation treatment of primary liver cancer.

Detailed description

The safety and effectiveness of the microwave ablation treatment system produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. for the ablation treatment of primary liver cancer is verified through the implementation of prospective, multi-center, single-group target value research. According to the requirements of the trial, 139 patients who were diagnosed with primary liver cancer before surgery and met the inclusion criteria without any exclusion criteria were selected for treatment of their liver cancer with a microwave ablation treatment system, 1 month, 3 months and 6 months after surgery Carry out clinical and imaging follow-up to evaluate the safety of the operation and the effect of tumor ablation.

Conditions

• Hepatocellular Carcinoma

Interventions

Type	Name	Description
DEVICE	microwave ablation	ultrasound-guided microwave ablation is performed to treat hepatocellular carcinoma patients

Timeline

• Start date: 2020-12-17
• Primary completion: 2022-04-06
• Completion: 2023-04-01
• First posted: 2020-08-20
• Last updated: 2025-07-01

Locations

13 sites across 1 country: China